课题基金 / 基金详情

Harnessing cross-reactive T cell receptors to eliminate latent HIV reservoirs

Harnessing cross-reactive T cell receptors to eliminate latent HIV reservoirs
利用交叉反应性 T 细胞受体消除潜在的 HIV 病毒库
批准号：
390986
负责人：
Brockman Mark A
金额：
$51.62万
依托单位：
Simon Fraser University (Burnaby, B.C.)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=390986&lang=en
关键词：
Antigen Cross-Reactivity Antigen Sensitivity Hiv/Aids Immune Escape, Immune Evasion Immunotherapy T Cell Receptor Vaccine Viral Latency, Persistence

项目摘要

项目成果

Brockman Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Combination antiretroviral therapy (cART) is highly effective at controlling HIV replication. However, cART does not eliminate cellular reservoirs consisting of latent virus-infected cells and therefore it must be maintained for life to avoid recurrent d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID-19 vaccines
Canada Research Chair Tier 2
2nd Afri-Can Forum of CHVI-funded HIV Prevention and Vaccine Teams
Barriers to engaging young people in HIV vaccine trials in a priority setting.
海外基金